- Citing a growing patient pool and an expansion of offerings into kidney failure-related medical fields, Fresenius Medical Care (FMS +2.6%) forecasts its top line to double to $28B by 2020.
- The number of global dialysis patients should grow 6.3%/year, slightly lower than the 6.8% rate over the past 13 years.
- The company believes it is well-positioned to take advantage of the transition from payments for individual services to lump-sum payments per dialysis session.
- (DVA +0.3%)
Dialysis firm sees positive revenue growth ahead
From other sites
at Zacks.com (Feb 26, 2015)
at MarketWatch.com (Jan 8, 2015)
at Nasdaq.com (Dec 29, 2014)
at CNBC.com (May 6, 2014)
at MarketWatch.com (Nov 25, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs